Lumbar disc herniation
Conditions
Interventions
treatment group:In addition to the control group, patients were given Wenjing Tongluo Powder (obtained from the prescription service center of the Wuxi Affiliated Hospital of Nanjing University of Tra
control group:Give Celecoxib Capsules (0.2g Pfizer) (Approval Number: CNPq J20120063) 1 capsule each time once a day for 4 weeks.
Sponsors
Wuxi Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Patients meeting the diagnostic criteria for lumbar disc herniation of the cold-damp paralysis type; (2) Age between 18 and 65 years old regardless of gender; (3) If the subject has been treated by other methods he/she has passed the elution period of more than 7 days; (4) The patient and his/her family members are informed and have signed an informed consent form for entering the study; (5) No serious heart brain liver kidney or blood system diseases.
Exclusion criteria
Exclusion criteria: (1) Those who did not meet the inclusion criteria; and (2) Patients with a clear diagnosis of lumbar disc herniation who have had unsatisfactory results after 3 months of strict conservative treatment; and (3) Patients with muscle paralysis saddle sensation and abnormal bowel function after spinal nerve compression; (4) Patients with a clear diagnosis of lumbar disc herniation who have failed to achieve good results after 3 months of strict conservative treatment. (4) Patients who are unable to move or even sleep due to severe pain and are in a forced position; imaging tests show that the intervertebral disc has ruptured the fibrous ring and the nucleus pulposus is in a ruptured position. Imaging examination shows intervertebral disc fibrous ring rupture free nucleus pulposus (5) Those who are allergic to the drugs used in this study; and (6) Active peptic ulcer or gastrointestinal bleeding; (7) The presence of a peptic ulcer or gastrointestinal bleeding; (8) The presence of a peptic ulcer or gastrointestinal bleeding. (7 ) Women who are pregnant or breastfeeding; and (8 ) Combined presence of serious cardiovascular and cerebrovascular diseases or hepatic or renal insufficiency; and (9) People with mental illness who cannot cooperate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantitative scoring of Chinese medicine evidence; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analogue scale;Japanese Orthopaedic Associationscores; | — |
Countries
China
Contacts
Public ContactZhang Xian
Wuxi Hospital of Traditional Chinese Medicine
Outcome results
None listed